The adhesion function of the sodium channel beta subunit (β1) contributes to cardiac action potential propagation

  1. Rengasayee Veeraraghavan  Is a corresponding author
  2. Gregory S Hoeker
  3. Anita Alvarez-Laviada
  4. Daniel Hoagland
  5. Xiaoping Wan
  6. D Ryan King
  7. Jose Sanchez-Alonso
  8. Chunling Chen
  9. Jane Jourdan
  10. Lori L Isom
  11. Isabelle Deschenes
  12. James Smyth
  13. Julia Gorelik
  14. Steven Poelzing
  15. Robert G Gourdie  Is a corresponding author
  1. Virginia Polytechnic University, United States
  2. Imperial College London, United Kingdom
  3. Case Western Reserve University, United States
  4. University of Michigan Medical School, United States

Abstract

Computational modeling indicates that cardiac conduction may involve ephaptic coupling - intercellular communication involving electrochemical signaling across narrow extracellular clefts between cardiomyocytes. We hypothesized that β1(SCN1B) - mediated adhesion scaffolds trans-activating NaV1.5 (SCN5A) channels within narrow (<30 nm) perinexal clefts adjacent to gap junctions (GJs), facilitating ephaptic coupling. Super-resolution imaging indicated preferential β1 localization at the perinexus, where it co-locates with NaV1.5. Smart patch clamp (SPC) indicated greater sodium current density (INa) at perinexi, relative to non-junctional sites. A novel, rationally designed peptide, βadp1, potently and selectively inhibited β1-mediated adhesion, in electric cell-substrate impedance sensing studies. βadp1 significantly widened perinexi in guinea pig ventricles, and selectively reduced perinexal INa, but not whole cell INa, in myocyte monolayers. In optical mapping studies, βadp1 precipitated arrhythmogenic conduction slowing. In summary, β1-mediated adhesion at the perinexus facilitates action potential propagation between cardiomyocytes, and may represent a novel target for anti-arrhythmic therapies.

Data availability

The raw data generated in this study is available via Dryad (doi:10.5061/dryad.10351qn). The raw STORM movies are available on request from the corresponding author due to their large size.

The following data sets were generated

Article and author information

Author details

  1. Rengasayee Veeraraghavan

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    For correspondence
    saiv@vt.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8364-2222
  2. Gregory S Hoeker

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Anita Alvarez-Laviada

    Department of Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Daniel Hoagland

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Xiaoping Wan

    Department of Medicine, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. D Ryan King

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jose Sanchez-Alonso

    Department of Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Chunling Chen

    Department of Pharmacology, University of Michigan Medical School, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Jane Jourdan

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Lori L Isom

    Department of Pharmacology, University of Michigan Medical School, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Isabelle Deschenes

    Department of Medicine, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. James Smyth

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Julia Gorelik

    Department of Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Steven Poelzing

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Robert G Gourdie

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    For correspondence
    gourdier@vtc.vt.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6021-0796

Funding

National Heart, Lung, and Blood Institute (RO1 HL56728-15A2)

  • Robert G Gourdie

American Heart Association (16SDG29870007)

  • Rengasayee Veeraraghavan

National Heart, Lung, and Blood Institute (R01 HL102298-01A1)

  • Steven Poelzing

National Institutes of Health (R01 HL102298-01A1)

  • James Smyth

National Institutes of Health (R37NS076752)

  • Lori L Isom

National Heart, Lung, and Blood Institute (RO1 HL HL141855-01)

  • Robert G Gourdie

National Heart, Lung, and Blood Institute (RO1 HL HL141855-01)

  • Steven Poelzing

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Robert S Kaas, Columbia University Medical Center, United States

Ethics

Animal experimentation: The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). All animal study protocols (15-130, 15-134, 12-140) were approved by the Institutional Animal Care and Use Committee at the Virginia Polytechnic University.

Version history

  1. Received: April 17, 2018
  2. Accepted: August 6, 2018
  3. Accepted Manuscript published: August 14, 2018 (version 1)
  4. Accepted Manuscript updated: August 16, 2018 (version 2)
  5. Version of Record published: September 4, 2018 (version 3)
  6. Version of Record updated: October 19, 2018 (version 4)
  7. Version of Record updated: November 30, 2022 (version 5)

Copyright

© 2018, Veeraraghavan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,247
    views
  • 452
    downloads
  • 91
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rengasayee Veeraraghavan
  2. Gregory S Hoeker
  3. Anita Alvarez-Laviada
  4. Daniel Hoagland
  5. Xiaoping Wan
  6. D Ryan King
  7. Jose Sanchez-Alonso
  8. Chunling Chen
  9. Jane Jourdan
  10. Lori L Isom
  11. Isabelle Deschenes
  12. James Smyth
  13. Julia Gorelik
  14. Steven Poelzing
  15. Robert G Gourdie
(2018)
The adhesion function of the sodium channel beta subunit (β1) contributes to cardiac action potential propagation
eLife 7:e37610.
https://doi.org/10.7554/eLife.37610

Share this article

https://doi.org/10.7554/eLife.37610

Further reading

    1. Cell Biology
    Ruichen Yang, Hongshang Chu ... Baojie Li
    Research Article

    Elastic cartilage constitutes a major component of the external ear, which functions to guide sound to the middle and inner ears. Defects in auricle development cause congenital microtia, which affects hearing and appearance in patients. Mutations in several genes have been implicated in microtia development, yet, the pathogenesis of this disorder remains incompletely understood. Here, we show that Prrx1 genetically marks auricular chondrocytes in adult mice. Interestingly, BMP-Smad1/5/9 signaling in chondrocytes is increasingly activated from the proximal to distal segments of the ear, which is associated with a decrease in chondrocyte regenerative activity. Ablation of Bmpr1a in auricular chondrocytes led to chondrocyte atrophy and microtia development at the distal part. Transcriptome analysis revealed that Bmpr1a deficiency caused a switch from the chondrogenic program to the osteogenic program, accompanied by enhanced protein kinase A activation, likely through increased expression of Adcy5/8. Inhibition of PKA blocked chondrocyte-to-osteoblast transformation and microtia development. Moreover, analysis of single-cell RNA-seq of human microtia samples uncovered enriched gene expression in the PKA pathway and chondrocyte-to-osteoblast transformation process. These findings suggest that auricle cartilage is actively maintained by BMP signaling, which maintains chondrocyte identity by suppressing osteogenic differentiation.

    1. Cancer Biology
    2. Cell Biology
    Timothy J Walker, Eduardo Reyes-Alvarez ... Lois M Mulligan
    Research Article

    Internalization from the cell membrane and endosomal trafficking of receptor tyrosine kinases (RTKs) are important regulators of signaling in normal cells that can frequently be disrupted in cancer. The adrenal tumor pheochromocytoma (PCC) can be caused by activating mutations of the rearranged during transfection (RET) receptor tyrosine kinase, or inactivation of TMEM127, a transmembrane tumor suppressor implicated in trafficking of endosomal cargos. However, the role of aberrant receptor trafficking in PCC is not well understood. Here, we show that loss of TMEM127 causes wildtype RET protein accumulation on the cell surface, where increased receptor density facilitates constitutive ligand-independent activity and downstream signaling, driving cell proliferation. Loss of TMEM127 altered normal cell membrane organization and recruitment and stabilization of membrane protein complexes, impaired assembly, and maturation of clathrin-coated pits, and reduced internalization and degradation of cell surface RET. In addition to RTKs, TMEM127 depletion also promoted surface accumulation of several other transmembrane proteins, suggesting it may cause global defects in surface protein activity and function. Together, our data identify TMEM127 as an important determinant of membrane organization including membrane protein diffusability and protein complex assembly and provide a novel paradigm for oncogenesis in PCC where altered membrane dynamics promotes cell surface accumulation and constitutive activity of growth factor receptors to drive aberrant signaling and promote transformation.